Since MGCD516 can inhibit RTKs such as PDGFR and VEGFR, we speculate that the significant tumor suppression achieved in vivo is not only limited to inhibition of signaling pathways in tumor cells but also due to an effect on stromal cell signaling mediated via these kinases. Here, PDGFRB is linked to neoplasm.